NICE relents and okays Akcea’s rare disease drug Waylivra for NHS usePatients with the rare disease familial chylomicronemia syndrome (FCS) will be able to access treatment with Akcea’s Waylivra Share XNICE relents and okays Akcea’s rare disease drug Waylivra for NHS usehttps://pharmaphorum.com/news/nice-relents-and-okays-akceas-rare-disease-drug-waylivra-for-nhs-use/
US regulators reject Akcea and Ionis rare disease drugThe US Food and Drug Administration (FDA) rejected Akcea and Ionis’ application for the use of Waylivra in Share XUS regulators reject Akcea and Ionis rare disease drughttps://pharmaphorum.com/news/us-regulators-reject-akcea-ionis-rare-disease-drug/
